Results

Total Results: 1,528 records

Showing results for "drugs".

  1. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-1-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…
  3. S143 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/s143.pdf
    October 01, 2007 - Key Words: cohort studies, propensity scores, observational research (Med Care 2007;45: S143–S148) Drugs … Statins inhibit endogenous cholesterol synthesis, and ther- apy with these drugs improves lipoprotein … including ambulatory care, approved specialists and outside referrals, laboratory work, and prescription drugs
  4. effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
    May 29, 2025 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…
  5. effectivehealthcare.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
    June 01, 2018 - have been diagnosed with delirium using a validated instrument • Interventions: o Antipsychotic drugs … , risperidone, ziprasidone) o We will only include studies where the effects of the antipsychotic drugs … quetiapine, risperidone, ziprasidone) • We will exclude studies where the effects of the antipsychotic drugs
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-protocol-acute-pain-treatments.pdf
    August 08, 2019 - therapy versus: 1) nonopioid pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … effectiveness of nonopioid pharmacologic therapy (e.g., acetaminophen, nonsteroidal anti-inflammatory drugs … nonopioid pharmacological therapy used for acute pain (acetaminophen, nonsteroidal anti-inflammatory drugs … Opioid analgesics—risky drugs, not risky patients. … A systematic review and meta-analysis comparing the efficacy of nonsteroidal anti-inflammatory drugs
  7. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
    April 01, 2010 - New chemotherapy regimen was defined only for the retrospective cohort using Medicare J-codes for drugs … used by Earle.8 Additional J-codes for chemotherapy were identified for chemotherapy drugs that had … • PACE/ PAAD NDC codes for drugs listed in Appendix 2. … • PACE/ PAAD NDC codes for drugs listed in Appendix 2. … • PACE/ PAAD NDC codes for drugs listed in Appendix 2.
  8. effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
    April 01, 2015 - The overview and network analysis were too recent to include the newest approved drugs, such as fingolimod … to correlate with the frequency and severity of side effects.7 The injectable treatments, the IFN drugs … There are no class A drugs (drugs safe for use during pregnancy according to the FDA) for MS. … one that is more effective or more tolerable, and studies have found high rates of switching between drugs … Newly approved drugs, such as fingolimod, and drugs in the development pipeline are emphasizing oral
  9. effectivehealthcare.ahrq.gov/sites/default/files/related_files/allergy-seasonal_disposition-comments.pdf
    July 17, 2013 - This has been corrected in the “Description of Included Studies” for this comparison, in Table 10 (Drugs … in pregnancy at least for orally inhaled cromolyn Sentence revised to list Pregnancy Category B drugs … : “Preferred treatments are Pregnancy Category B drugs (nasal cromolyn, budesonide, and ipratropium … before an intranasal corticosteroid or an intranasal antihistamine to increase delivery of these drugs … before an intranasal corticosteroid or an intranasal antihistamine to increase delivery of these drugs
  10. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disposition-of-comments-cer-192-anxiety-in-children.pdf
    August 31, 2017 - 2017 Commentator & Affiliation Section Comment Response TEP 2 Methods p. 15 CBT vs Drugs … Results Page 25, key points: the authors might clarify that both of the RCTs comparing CBT to drugs … At a minimum, it would be helpful to indicate what class of drugs each comparison comes from (e.g. … For example, in the section “CBT combined with drugs” and subsection “Sertraline vs. … Of note, the original Walkup et al. 2008 study is cited in other comparisons of interest (drugs versus
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-pregnancy-postpartum_disposition-comments.pdf
    July 08, 2014 - #10 ES 5 (p. 13) Interventions Reword 2nd sentence to avoid using double “nots” Changed to: “Drugs … risk of neonatal withdrawal symptoms or pulmonary hypertension with maternal use of antidepressant drugs … to improve some symptoms based on evidence in nonpregnant patients, it is possible that individual drugs … to improve some symptoms based on evidence in nonpregnant patients, it is possible that individual drugs … to improve some symptoms based on evidence in nonpregnant patients, it is possible that individual drugs
  12. effectivehealthcare.ahrq.gov/sites/default/files/pdf/abnormal-uterine-bleeding_research-protocol.pdf
    November 21, 2011 - progestogens, combination (estrogen and progestogen) hormonal formulations, nonsteroidal anti-inflammatory drugs … longer commonly prescribed for related indications (e.g., the synthetic androgen– Danazol) nor for drugs … Interventions 1 :  Medical therapies o Nonsteroidal anti-inflammatory drugs o Antifibrinolytics … compounds that are no longer commonly prescribed, such as the synthetic androgen Danazol, as well as drugs … Interventions for Abnormal Uterine Bleeding Nonsteroidal anti-inflammatory drugs (NSAIDs)  Ibuprofen
  13. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - We were asked to study the use of these drugs for the following conditions: 1) pervasive developmental … Intervention drugs of interest The intervention drug must be an FDA-approved first or second generation … These drugs include: aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine … Comparison drugs of interest http://www.effectivehealthcare.ahrq.gov/� Source: www.effectivehealthcare.ahrq.gov … co-morbidities, use of concurrent standard medical therapies), details of the intervention and comparator (drugs
  14. Untitled (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/thromboembolism-update_research-protocol.pdf
    February 17, 2016 - history of abnormal surgical bleeding or bleeding disorder, prior medications (including antiplatelet drugs … of abnormal surgical bleeding or bleeding disorder o   Prior medications (especially antiplatelet drugs … surgical   bleeding   History  of  bleeding  disorder   Prior  medications  (especially   antiplatelet  drugs … Available drugs are anticoagulants that lower the likelihood that blood clots.
  15. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/atypical-antipsychotics-off-label_executive.pdf
    January 01, 2007 - These drugs have been studied for off-label use in the following conditions: dementia and severe geriatric … How do atypical antipsychotic medications compare with other drugs for treating off- label indications … Effectiveness and comparison with other drugs Dementia-agitation and behavioral disorders A recent … Both drugs were associated with an increase in EPS (OR: 2.53 and 2.82, respectively) compared to placebo
  16. effectivehealthcare.ahrq.gov/sites/default/files/pdf/antidepressants-update_research-protocol.pdf
    July 13, 2011 - These drugs work, at least in part, through their effects on neurotransmitters such as serotonin, norepinephrine … somatization), KQ4 focuses on safety issues (adverse effects, adherence) with each of the different study drugs … or combinations of study drugs.
  17. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … Results The table below lists the two topics for which (1) preliminary phase III data for drugs or
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/autoimmune-disease-rapid-research.pdf
    November 01, 2024 - studies had patients who were on either conventional or biologic disease-modifying anti-rheumatic drugs … A class of therapeutic agents called DMARDs (disease-modifying anti-rheumatic drugs) has been in use … yr 12.2% Abbreviations: csDMARDs: conventional synthetic disease-modifying anti-rheumatic drugs … ; DMARDs: disease-modifying anti-rheumatic drugs; mo: month; NR: not reported; NSAIDs: nonsteroidal … Mechanisms of Action of Disease Modifying Antirheumatic Drugs. J Rheumatol Suppl 1992, 32, 100–103
  19. effectivehealthcare.ahrq.gov/sites/default/files/diverticulitis-nomination-extra.pdf
    May 29, 2025 - Management of Acute Diverticulitis Additional Information for Topic Nomination Table 1. Key Questions and PICOTS KQ1: Antibiotics KQ1: Antibiotics vs. No Antibiotics KQ2: Diagnostic imaging KQ3: Follow-up colonoscopy KQ4: Surgical and interventional management KQ5: Prevention of recurrence Populat…
  20. effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0583-131115.pdf
    March 13, 2013 - A systematic review will outline the most effective choices among new drugs and monitoring strategies

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: